Fcf Advisors LLC Edwards Lifesciences Corp Transaction History

Fcf Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 06, 2021	SELL	$78.68 - $90.67 $1.5 Million - $1.73 Million	-19,072 Closed	0 $0
Q4 2020 Jan 12, 2021	SELL	$71.69 - $91.23 $127,966 - $162,845	-1,785 Reduced 8.56%	19,072 $1.69 Million
Q3 2020 Oct 20, 2020	BUY	$67.19 - $87.44 $503,723 - $655,537	7,497 Added 56.12%	20,857 $1.75 Million
Q2 2020 Jul 10, 2020	BUY	$57.54 - $76.95 $501,115 - $670,157	8,709 Added 187.25%	13,360 $924,000
Q1 2020 Apr 21, 2020	SELL	$52.41 - $81.0 $24,527 - $37,908	-468 Reduced 9.14%	4,651 $921,000
Q4 2019 Jan 07, 2020	BUY	$71.7 - $82.09 $367,032 - $420,218	5,119 New	5,119 $1.2 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Fcf Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Fcf Advisors LLC with notifications on news.